Opportunities in Oncology

There is still a long way to go to build capacity in oncology care, but with huge investor interest, linked to the close synergies with imaging diagnostics, the opportunities are huge. Add in public sector outsourcing and there’s a lot of room for growth. This session explores the opportunities and analyses the best models to build capacity. Ralf Kurek heads up one of the largest players in the sector internationally.

Speakers include:

Dr Ralf Kurek, Executive Partner, RadioOnkologieNetzwerk, Ergéa Group Ralph Hefti, CEO, Stingray Healthcare Nikos Paragios, CEO, TheraPanacea Moderated by Joe Quiruga, Analyst, HBI

Radiotherapy and outpatient oncology is another key sector for consolidation across Europe with investors such as DWS, owners of RON through Medipass, and Infravia building Pan-European chains. Here Ralf takes the lid off RON’s business model